Login / Signup
Regulatory Action to Protect Access to Hydroxychloroquine for Approved Rheumatic Indications During COVID-19 in New Zealand.
Eamon J Duffy
Nicola Arroll
Richard Beasley
Thomas E Hills
Published in:
Arthritis & rheumatology (Hoboken, N.J.) (2021)
Keyphrases
</>
rheumatoid arthritis
drug administration
transcription factor